Main Menu

Professional activities

Awards, Prizes or Honours

Fellow of the Academy of Medical Sciences, Academy of Medical Sciences, 2012.

Bronze Clinical Excellence Award (extended for further 5 years), Royal Marsden NHS Foundation Trust, 2010.

AACR Highly Rated Paper, American Association for Cancer Research, 2009.

NIHR Senior Investigator, National Institute of Health Research, 2008, 2011.

Bronze Clinical Excellence Award, Royal Marsden NHS Foundation Trust, 2005.

Editorial Boards

Cancer Medicine, 2012.

Prostate Cancer and Prostastic Disease, 2000-2011.

Hereditary Cancer in Clinical Practice, 2007.

Oncogene, 2007.

International Journal of Cancer, 2008.

BJU International, 2008.

Prostate Cancer, 2010-2011.

Open Journal of Genomics, 2010.

External Committees

Economics Returns to Cancer Research Advisory Group, Member, CR-UK, 2012-2012.

Prostate Clinical Studies Group, Member, NCRI, 2012.

. Fellow, Academy of Medical Sciences, 2012.

Tissue Management System Project Team, Member, The Institute of Cancer Research, 2012.

Expert Advisory Group on Data Access, Member, Wellcome Trust, MRC. ESRC, CR-UK, 2012.

ICR Information Governance Group, Member, The Institute of Cancer Research, 2011-2011.

Steering Committee, Member, The Cancer Genetics Group, 2009-2013.

Steering Committee, Founder and Chairman, CEC: Clinical Ellipse Consortium, 2011.

Prospective Study Steering Committee, Member, POSH, 2010.

Advisory Committee for the Study of MRI Breast Sreening v Mammography in High Risk Women, Genetics Advisor, MARIBS, 2005.

Committee of ethnicity and access study, Member, Genetic Alliance, 2011-2012.

International Scientific Steering Committee, Member, ICGC International Cancer Genome Consortium, 2011.

Steering Committee, Member, ICPCG International Consortium for Prostate Cancer Genetics, 1996.

Prostate Cancer Association Study, Founder and Chairman, PRACTICAL, 2007.

Steering Committee, Founder and Chairman, IMPACT Study (The Identification of Men with Predisposition to Prostate Cancer: Targeted screening in BRCA1/2 mutation carriers, 2006.

Scientific Committee, Member, Prostate Action (Merger of PCRF and Prostate UK), 2011-2012.

Fellowship Selection Committee, Member, IARC (International Agency for Research on Cancer; World Health Organisation), 2006-2010.

Scientfic Committee, Member, Prostate Action, 2004-2012.

UK National/regional representative for the IHCC, Member, IHCC International Hereditary Cancer Committee (Poland), 2004-2011.

Clinical Fellows Selection Panel, Member, Cancer Research UK, 2011-2013.

Protocol Enhancements Review Committee, Member, UK Biobank, 2009-2011.

External Scientific Review Panel, Member, Wales Cancer Bank, 2008.

British Oncological Association Council, Member, British Oncological Association, 2002-2011.

Advisory Board, Member, SEEGen, 2006-2011.

Medical Advisory Panel, Member, Chai Cancer Care, 2008-2013.

Advisor to risks and benefits project, Advisor, Genetic Alliance, 2010-2012.